Imagen de Portada

Prognostic Implications of Programmed Cell Death Ligand 1 Expression, Cluster of Differentiation 8‐Positive T‐Cell Infiltration, and Related Immunophenotypes in Invasive Mucinous Adenocarcinoma of the Lung: A Multicenter Study

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Guochao Zhang, Chao Zheng, Jia Jia, Xingchen Li, Lide Wang, Long Zhang, Yuzhuo Zhang, Meng Yue, Shuangping Zhang, Yueping Liu, Liyan Xue, Qi Xue, Jie He
Formato:	Artículo Open Access
Publicado:	Wiley 2026
Materias:	MedComm
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Cell Death and Senescence‐Based Molecular Classification and an Individualized Prediction Model for Lung Adenocarcinoma
por: Pan Wang, et al.
Publicado: (2025)

Yin Yang 1 Promotes Antiprogrammed Cell Death‐1 Resistance in Hepatocellular Carcinoma through Polypeptide N‐Acetylgalactosaminyltransferase 16‐Mediated Glycosylation of Programmed Death Ligand‐1
por: Shu‐sheng Lin, et al.
Publicado: (2025)

Inducible T Cell Costimulator Ligand and Inducible T Cell Costimulator Stratification Identify Dichotomous Tumor Microenvironment and Guide Chemo‐Immunotherapy in Small Cell Lung Cancer
por: Qiji Guo, et al.
Publicado: (2026)

LungSurg: A Generative AI System for Segmentation and Phase Classification in Thoracoscopic Lobectomy
por: Hengrui Liang, et al.
Publicado: (2026)

Inhibiting ADAR1‐Mediated Excessive Epigenetic A‐to‐I RNA Editing Improves the Immune Microenvironment and Increases Sensitivity to Immunotherapy in Lung Adenocarcinoma
por: Sihui Wang, et al.
Publicado: (2026)

Genetic Subtype‐Based International Prognostic Index Prognostic Model in Diffuse Large B‐Cell Lymphoma
por: Lan Mi, et al.
Publicado: (2025)

A Combined Model Based on Bone Mineral Density for Noninvasive Prediction of Prognosis in Non‐Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A Multicenter Retrospective Study
por: Bingxin Gong, et al.
Publicado: (2025)

Mitochondria as Regulators of Nonapoptotic Cell Death in Cancer
por: Saloni Malla, et al.
Publicado: (2025)

Lactate: A Key Promoter of Cancer Stem Cells and Implications for Cancer Therapy
por: Yan Xue, et al.
Publicado: (2025)

Dynamic T‐Cell Reprogramming Modulates the Treatment Outcome of Neoadjuvant Immunochemotherapy in Non‐Small‐Cell Lung Cancer
por: Rui Jin, et al.
Publicado: (2026)

Sulforaphane Synergizes With PD‐1 Blockade Through Activating CD8 + T Cells in Non–Small Cell Lung Cancer: Preclinical and Clinical Investigations
por: Jieyao Li, et al.
Publicado: (2026)

Genome‐Wide 5‐Methylcytosine and 5‐Hydroxymethylcytosine Signatures Analysis of Plasma Cell‐Free DNA in Schizophrenia
por: Gang Xue, et al.
Publicado: (2025)

Dual MNK/VEGFR2 Inhibitor JDB153 Enhances Immunotherapeutic Efficiency and Chemosensitivity in Lung Cancer
por: Maosen Xu, et al.
Publicado: (2025)

Metabolic and Epigenetic Control of CD8+ T Cell Exhaustion: The Acetate‐to‐Citrate Switch
por: Xiaoyi Lei, et al.
Publicado: (2025)

Identifying the Intergenic ALK Fusion LOC388942‐ALK as a Driver of Non–Small Cell Lung Cancer
por: Xiaoqian Zhai, et al.
Publicado: (2025)

Cancer Stem Cells in Human Gastrointestinal and Hepatic Cancers
por: Jiawen Bu, et al.
Publicado: (2025)

Incidence of Metastasis in the Central Nervous System in Advanced Breast Cancer Treated With CDK 4/6 Inhibitors: A Multicenter, Retrospective Study
por: Yan‐Ling Wen, et al.
Publicado: (2025)

Single‐Cell and Spatial Multiomics: Applications for Diseases
por: Wentao Li, et al.
Publicado: (2025)

The Incremental Prognostic Value of Hyperemic Coronary Flow Velocity in Patients with Angina and Nonobstructive Coronary Artery Disease
por: Quande Liu, et al.
Publicado: (2026)

LncRNA SNHG5/miR‐363‐3p/USP28 Axis Promotes Lung Adenocarcinoma Progression Through Enhancing β‐Catenin Stabilization
por: Jia‐yu Zou, et al.
Publicado: (2025)

Tislelizumab Combined With Axitinib in Neoadjuvant Treatment of Locally Advanced Clear Cell Renal Cell Carcinoma: A Single‐Center, Phase II Clinical Study
por: Wenjin Yang, et al.
Publicado: (2026)

The Long Noncoding RNA LINC02820 Promotes Tumor Growth and Metastasis Through Regulating MYH9 Expression in Esophageal Squamous Cell Carcinoma
por: Xiaomin Xu, et al.
Publicado: (2025)

Parkinson's Disease: The Epidemiology, Risk Factors, Molecular Pathogenesis, Prevention, and Therapy
por: Xue‐Yao Guo, et al.
Publicado: (2025)

Long‐Term High‐Fat Diet Affected Bone Marrow Microenvironment During Aging at Single‐Cell Resolution
por: Yidan Pang, et al.
Publicado: (2025)

AI Algorithm for Lung Adenocarcinoma Pattern Quantification (PATQUANT): International Validation and Advanced Risk Stratification Superior to Conventional Grading
por: Yuan Wang, et al.
Publicado: (2025)

First‐Line Third‐Generation EGFR Tyrosine Kinase Inhibitor Monotherapy for Advanced EGFR‐Mutated Non‐Small Cell Lung Cancer: A Systematic Review and Network Meta‐Analysis
por: Wei Du, et al.
Publicado: (2025)

Nanobody‐Mediated c‐MYC Degradation Inhibits Tumor Cell Progression
por: Yuanyuan Xue, et al.
Publicado: (2026)

Genomic and Immune Profiling of Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Therapy Versus Upfront Surgery Identifies Novel Immunogenic Cell Death‐Based Signatures for Predicting Clinical Outcomes
por: Peidong Song, et al.
Publicado: (2025)

Innate Lymphoid Cells in Tissue Homeostasis and Diseases
por: Zhenzhen Zhan, et al.
Publicado: (2026)

Mucosal‐Associated Invariant T Cells: Origins, Biological Functions, Diseases, and Therapeutic Targets
por: Cheng Zhu, et al.
Publicado: (2025)

A Dose‐Tailored Anti‐Plasma Cell Regimen Lowers the Mortality of Late‐Stage Cardiac Amyloidosis
por: Yun Ti, et al.
Publicado: (2025)

Implant Renal Injury‐Responsive Cells to Supplement Erythropoietin and Protect Kidney Injury
por: Hao Nie, et al.
Publicado: (2025)

Cell death pathways: molecular mechanisms and therapeutic targets for cancer
por: Shaohui Wang, et al.
Publicado: (2024)

Protein palmitoylation: biological functions, disease, and therapeutic targets
por: Yan‐Ran Qian, et al.
Publicado: (2025)

Single‐Cell Transcriptomics Revealed E‐Cigarettes‐Induced Vascular Remodeling by Enhancing Tcf21 Expression
por: Ruiyang Ding, et al.
Publicado: (2025)

Natural Killer Cell‐Mediated Antitumor Immunity: Molecular Mechanisms and Clinical Applications
por: Nanzhi Luo, et al.
Publicado: (2025)

Non‐Invasive Assessment of Complete Regression in Endometrial Cancer Patients Undergoing Fertility Preservation Using MRI‐Based Radiomics and Immune Heterogeneity
por: Xingchen Li, et al.
Publicado: (2026)

Neoadjuvant Toripalimab Plus Axitinib for Nonmetastatic Clear Cell Renal Cell Carcinoma With Tumor Thrombus: A Combined Analysis of Two Phase II Clinical Trials
por: Cheng Peng, et al.
Publicado: (2026)

Progression and Metastasis of Lung Cancer: Clinical Features, Molecular Mechanisms, and Clinical Managements
por: Yunkui Zhang, et al.
Publicado: (2025)

Camrelizumab, an Anti‐PD‐1 Monoclonal Antibody, Plus Carboplatin and Nab‐Paclitaxel as First‐Line Setting for Extensive‐Stage Small‐Cell Lung Cancer: A Phase 2 Trial and Biomarker Analysis
por: Jia Yu, et al.
Publicado: (2025)